Sqz Biotechnologies Co logo

Sqz Biotechnologies Co Share Price (NYSE: SQZ)

▲

-0.43

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 3 Jul 2023

Check the interactive Sqz Biotechnologies Co Stock chart to analyse performance

Sqz Biotechnologies Co Key Stats

Check Sqz Biotechnologies Co key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.435
Open
$0.40995
Market Capitalization
$12.6M
Today's Volume
$30.2M
Revenue TTM
$18.6M
EBITDA
$-71.6M
Earnings Per Share (EPS)
$-2.16
Dividend Yield
0.0%
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-104.93%

Global Institutional Holdings in Sqz Biotechnologies Co

  • Name

    Holdings %

  • Temasek Holdings Ltd.

    9.35%

  • American International Group Inc

    8.54%

  • Artal Group S A

    5.45%

  • Maverick Capital Ltd

    3.57%

  • Vanguard Group Inc

    3.19%

  • Stifel Financial Corp

    2.96%

Analyst Recommendation on Sqz Biotechnologies Co Stock

Rating
Trend

Buy

    71%Buy

    28%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Sqz Biotechnologies Co(by analysts ranked 0 to 5 stars)

About Sqz Biotechnologies Co

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
Organization
Sqz Biotechnologies Co
Employees
53
CEO
Dr. Howard Bernstein M.D., Ph.D.
Industry
Health Technology

Important FAQs about investing in SQZ Stock from India :

What is Sqz Biotechnologies Co share price today?

Sqz Biotechnologies Co share price today is as on at the close of the market. Sqz Biotechnologies Co share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Sqz Biotechnologies Co share?

Sqz Biotechnologies Co share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Sqz Biotechnologies Co stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Sqz Biotechnologies Co Stock (SQZ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Sqz Biotechnologies Co on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Sqz Biotechnologies Co Shares .

What is the minimum amount required to buy Sqz Biotechnologies Co Stock (SQZ) from India?

Indian investors can start investing in Sqz Biotechnologies Co (SQZ) shares with as little as ₹88.73 or $1 (as of November 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹887.30 in Sqz Biotechnologies Co stock (as per the Rupee-Dollar exchange rate as on November 16, 2025). Learn more about fractional shares .

What are the returns that Sqz Biotechnologies Co has given to Indian investors in the last 5 years?

Sqz Biotechnologies Co stock has given 0.0% share price returns and 19.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?